Boehringer Ingelheim’s Jascayd (nerandomilast) tablets have been granted marketing authorisation by the Medicines and ...

Ipsen is set to acquire Memo Therapeutics in a deal worth more than €700m EUR that is focused on potravitug, a phase 2 ...

Alignment is not proven by whether teams are coordinated, it is proven by whether their combined efforts are sustained ...

The ranking of the top pharmaceutical companies has been compiled from GlobalData’s pharmaceutical revenue figures, which are based on sales of prescription medicines, including generics drugs. The ...

Teva Pharmaceutical has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) seeking approval ...

The UK’s challenge is less about capability and more about how well it aligns with the way global pharma now operates ...

Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals in a deal worth around $10.0bn. Crinetics is a global ...

Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful ...

Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences ...

Klick Health, a global, independent commercialisation partner for life sciences, has acquired Oxford PharmaGenesis, a ...

Novartis is set to acquire Myricx Bio, paying $1.1bn upfront, with up to $400m in potential milestone payments. The acquisition would strengthen Novartis’ oncology pipeline and advance next-generation ...